Logo image of BSL.DE

BASLER AG (BSL.DE) Stock Fundamental Analysis

FRA:BSL - Deutsche Boerse Ag - DE0005102008 - Common Stock - Currency: EUR

7.5  -0.13 (-1.7%)

Fundamental Rating

4

BSL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 49 industry peers in the Electronic Equipment, Instruments & Components industry. BSL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BSL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BSL had negative earnings in the past year.
In the past year BSL had a positive cash flow from operations.
Of the past 5 years BSL 4 years were profitable.
Each year in the past 5 years BSL had a positive operating cash flow.
BSL.DE Yearly Net Income VS EBIT VS OCF VS FCFBSL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

1.2 Ratios

The Return On Assets of BSL (-1.24%) is comparable to the rest of the industry.
BSL has a Return On Equity (-2.25%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.24%
ROE -2.25%
ROIC N/A
ROA(3y)3.98%
ROA(5y)5.4%
ROE(3y)7.14%
ROE(5y)9.41%
ROIC(3y)N/A
ROIC(5y)N/A
BSL.DE Yearly ROA, ROE, ROICBSL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

1.3 Margins

BSL's Gross Margin of 44.48% is fine compared to the rest of the industry. BSL outperforms 65.31% of its industry peers.
BSL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for BSL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.54%
GM growth 5Y-4.47%
BSL.DE Yearly Profit, Operating, Gross MarginsBSL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

More info and screens

5

2. Health

2.1 Basic Checks

BSL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BSL has more shares outstanding
Compared to 5 years ago, BSL has more shares outstanding
Compared to 1 year ago, BSL has a worse debt to assets ratio.
BSL.DE Yearly Shares OutstandingBSL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
BSL.DE Yearly Total Debt VS Total AssetsBSL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

BSL has an Altman-Z score of 2.80. This is not the best score and indicates that BSL is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of BSL (2.80) is better than 63.27% of its industry peers.
BSL has a debt to FCF ratio of 10.38. This is a negative value and a sign of low solvency as BSL would need 10.38 years to pay back of all of its debts.
BSL has a Debt to FCF ratio (10.38) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.49 indicates that BSL is not too dependend on debt financing.
The Debt to Equity ratio of BSL (0.49) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 10.38
Altman-Z 2.8
ROIC/WACCN/A
WACC5.86%
BSL.DE Yearly LT Debt VS Equity VS FCFBSL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

BSL has a Current Ratio of 2.66. This indicates that BSL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.66, BSL belongs to the best of the industry, outperforming 81.63% of the companies in the same industry.
BSL has a Quick Ratio of 1.52. This is a normal value and indicates that BSL is financially healthy and should not expect problems in meeting its short term obligations.
BSL has a better Quick ratio (1.52) than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 1.52
BSL.DE Yearly Current Assets VS Current LiabilitesBSL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 80.59% over the past year.
The Revenue for BSL has decreased by -18.39% in the past year. This is quite bad
The Revenue has been growing slightly by 6.07% on average over the past years.
EPS 1Y (TTM)80.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.15%
Revenue 1Y (TTM)-18.39%
Revenue growth 3Y5.8%
Revenue growth 5Y6.07%
Sales Q2Q%3.7%

3.2 Future

Based on estimates for the next years, BSL will show a very strong growth in Earnings Per Share. The EPS will grow by 39.29% on average per year.
BSL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.52% yearly.
EPS Next Y83.93%
EPS Next 2Y51.19%
EPS Next 3Y39.29%
EPS Next 5YN/A
Revenue Next Year-11.09%
Revenue Next 2Y-4.09%
Revenue Next 3Y0.95%
Revenue Next 5Y8.52%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BSL.DE Yearly Revenue VS EstimatesBSL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
BSL.DE Yearly EPS VS EstimatesBSL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.5 -0.5 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

BSL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 46.41 indicates a quite expensive valuation of BSL.
The rest of the industry has a similar Price/Forward Earnings ratio as BSL.
The average S&P500 Price/Forward Earnings ratio is at 22.10. BSL is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 46.41
BSL.DE Price Earnings VS Forward Price EarningsBSL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BSL is valued a bit more expensive than the industry average as 67.35% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BSL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 31.93
EV/EBITDA 37.92
BSL.DE Per share dataBSL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

BSL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BSL's earnings are expected to grow with 39.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.19%
EPS Next 3Y39.29%

More info and screens

2

5. Dividend

5.1 Amount

BSL has a Yearly Dividend Yield of 1.52%. Purely for dividend investing, there may be better candidates out there.
BSL's Dividend Yield is comparable with the industry average which is at 3.31.
Compared to the average S&P500 Dividend Yield of 2.33, BSL is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.52%

5.2 History

The dividend of BSL decreases each year by -9.06%.
Dividend Growth(5Y)-9.06%
Div Incr Years0
Div Non Decr Years0
BSL.DE Yearly Dividends per shareBSL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y51.19%
EPS Next 3Y39.29%
BSL.DE Yearly Income VS Free CF VS DividendBSL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

More info and screens

BASLER AG

FRA:BSL (3/7/2025, 7:00:00 PM)

7.5

-0.13 (-1.7%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-07 2024-11-07
Earnings (Next)03-28 2025-03-28/amc
Inst Owners25.53%
Inst Owner ChangeN/A
Ins Owners6.63%
Ins Owner ChangeN/A
Market Cap236.25M
Analysts74
Price Target14.28 (90.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.52%
Yearly Dividend0.14
Dividend Growth(5Y)-9.06%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-260%
EPS NY rev (3m)-208%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.84%
Revenue NY rev (3m)-4.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 46.41
P/S 1.3
P/FCF 31.93
P/OCF 13.81
P/B 1.79
P/tB 5.97
EV/EBITDA 37.92
EPS(TTM)-0.1
EYN/A
EPS(NY)0.16
Fwd EY2.15%
FCF(TTM)0.23
FCFY3.13%
OCF(TTM)0.54
OCFY7.24%
SpS5.77
BVpS4.19
TBVpS1.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.24%
ROE -2.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.48%
FCFM 4.07%
ROA(3y)3.98%
ROA(5y)5.4%
ROE(3y)7.14%
ROE(5y)9.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.54%
GM growth 5Y-4.47%
F-Score5
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 10.38
Debt/EBITDA 8.8
Cap/Depr 52.13%
Cap/Sales 5.34%
Interest Coverage N/A
Cash Conversion 233.01%
Profit Quality N/A
Current Ratio 2.66
Quick Ratio 1.52
Altman-Z 2.8
F-Score5
WACC5.86%
ROIC/WACCN/A
Cap/Depr(3y)110.84%
Cap/Depr(5y)140.45%
Cap/Sales(3y)8.36%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.15%
EPS Next Y83.93%
EPS Next 2Y51.19%
EPS Next 3Y39.29%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.39%
Revenue growth 3Y5.8%
Revenue growth 5Y6.07%
Sales Q2Q%3.7%
Revenue Next Year-11.09%
Revenue Next 2Y-4.09%
Revenue Next 3Y0.95%
Revenue Next 5Y8.52%
EBIT growth 1Y-4.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year223.31%
EBIT Next 3Y73.64%
EBIT Next 5YN/A
FCF growth 1Y128.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3143.24%
OCF growth 3Y-51.6%
OCF growth 5Y-30.98%